Peel Hunt reiterated their hold rating on shares of Horizon Discovery Group (LON:HZD) in a report issued on Thursday.

Separately, Numis Securities reaffirmed a buy rating on shares of Horizon Discovery Group in a report on Monday, September 17th.

LON HZD traded down GBX 1 ($0.01) during mid-day trading on Thursday, hitting GBX 182 ($2.38). The company’s stock had a trading volume of 6,598 shares, compared to its average volume of 258,981. Horizon Discovery Group has a twelve month low of GBX 160 ($2.09) and a twelve month high of GBX 294 ($3.84).

Horizon Discovery Group Company Profile

Horizon Discovery Group plc, an integrated life science company, designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments.

Featured Article: What are the Different Types of Leveraged Buyouts?

Receive News & Ratings for Horizon Discovery Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group and related companies with's FREE daily email newsletter.